Cooper Companies operates in the healthcare sector, primarily focusing on the development and manufacturing of contact lenses and surgical instruments. Its core products include silicone hydrogel contact lenses and various ophthalmic surgical devices. The company is divided into two main segments: CooperVision, which specializes in vision care products, and CooperSurgical, which provides medical devices and fertility solutions. Major revenue sources stem from the sale of contact lenses and surgical instruments, catering to both consumer and healthcare professional markets.
The investment profile of Cooper Companies is more aligned with balanced investors, given its stable revenue streams and moderate growth potential. The absence of a dividend yield suggests a focus on reinvestment rather than income generation. The stock's performance indicates a cautious approach, suitable for those seeking a mix of growth and stability without high volatility.
| Date | Avant | Après | Raison |
|---|---|---|---|
| 2026-06-13 02:37 | Vendre | Conserver | Positive EPS surprise, but mixed momentum signals. |
| 2026-05-20 02:39 | Conserver | Vendre | Weak fundamentals and negative momentum raise concerns. |
| 2026-05-08 14:58 | — | Conserver | Weak fundamentals and negative momentum raise significant concerns. |
| Date | Analyste | Action | Objectif | Prix alors |
|---|---|---|---|---|
| 2026-06-05 10:09 | Needham | Objectif abaissé | — → 86 | 62.02 |
| 2026-06-05 09:24 | Wells Fargo | Objectif abaissé | — → 66 | 62.02 |
| 2026-06-04 10:49 | Mizuho Securities | Objectif abaissé | — → 85 | 60.34 |
